197 related articles for article (PubMed ID: 26170162)
21. Development of virus-like particle technology from small highly symmetric to large complex virus-like particle structures.
Pushko P; Pumpens P; Grens E
Intervirology; 2013; 56(3):141-65. PubMed ID: 23594863
[TBL] [Abstract][Full Text] [Related]
22. A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines.
Middelberg AP; Rivera-Hernandez T; Wibowo N; Lua LH; Fan Y; Magor G; Chang C; Chuan YP; Good MF; Batzloff MR
Vaccine; 2011 Sep; 29(41):7154-62. PubMed ID: 21651936
[TBL] [Abstract][Full Text] [Related]
23. Antigen delivery by virus-like particles for immunotherapeutic vaccination.
Al-Barwani F; Donaldson B; Pelham SJ; Young SL; Ward VK
Ther Deliv; 2014 Nov; 5(11):1223-40. PubMed ID: 25491672
[TBL] [Abstract][Full Text] [Related]
24. The True Story and Advantages of RNA Phage Capsids as Nanotools.
Pumpens P; Renhofa R; Dishlers A; Kozlovska T; Ose V; Pushko P; Tars K; Grens E; Bachmann MF
Intervirology; 2016; 59(2):74-110. PubMed ID: 27829245
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
[TBL] [Abstract][Full Text] [Related]
26. Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirus.
Yong CY; Yeap SK; Goh ZH; Ho KL; Omar AR; Tan WS
Appl Environ Microbiol; 2015 Feb; 81(3):882-9. PubMed ID: 25416760
[TBL] [Abstract][Full Text] [Related]
27. Chimeric virus-like particles made using GAG and M1 capsid proteins providing dual drug delivery and vaccination platform.
Deo VK; Kato T; Park EY
Mol Pharm; 2015 Mar; 12(3):839-45. PubMed ID: 25627427
[TBL] [Abstract][Full Text] [Related]
28. A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice.
Jiang L; Fan R; Sun S; Fan P; Su W; Zhou Y; Gao F; Xu F; Kong W; Jiang C
Vaccine; 2015 Nov; 33(48):6596-603. PubMed ID: 26529072
[TBL] [Abstract][Full Text] [Related]
29. Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine.
Sundararajan A; Sangster MY; Frey S; Atmar RL; Chen WH; Ferreira J; Bargatze R; Mendelman PM; Treanor JJ; Topham DJ
Vaccine; 2015 Jan; 33(4):568-76. PubMed ID: 25444793
[TBL] [Abstract][Full Text] [Related]
30. Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography.
Huhti L; Tamminen K; Vesikari T; Blazevic V
Arch Virol; 2013 May; 158(5):933-42. PubMed ID: 23229011
[TBL] [Abstract][Full Text] [Related]
31. Virus-Like Particle Engineering: From Rational Design to Versatile Applications.
Ding X; Liu D; Booth G; Gao W; Lu Y
Biotechnol J; 2018 May; 13(5):e1700324. PubMed ID: 29453861
[TBL] [Abstract][Full Text] [Related]
32. Establishment of a novel method without sequence modification for developing NoV P particle-based chimeric vaccines.
Li Y; Fu L; Hu Y; Jin H; Zheng Y; Yin Y; Wu H; Yu X; Kong W
Protein Expr Purif; 2016 May; 121():73-80. PubMed ID: 26773744
[TBL] [Abstract][Full Text] [Related]
33. Expression and characterization of hepatitis E virus-like particles and non-virus-like particles from insect cells.
Qi Y; Fan J; Huang W; Zhao C; Wang Y; Kong FT; Kong W; Jiang C
Biotechnol Appl Biochem; 2016 May; 63(3):362-70. PubMed ID: 25824972
[TBL] [Abstract][Full Text] [Related]
34. Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform.
Caldeira J; Bustos J; Peabody J; Chackerian B; Peabody DS
PLoS One; 2015; 10(10):e0141407. PubMed ID: 26516771
[TBL] [Abstract][Full Text] [Related]
35. The application of virus-like particles as vaccines and biological vehicles.
Yan D; Wei YQ; Guo HC; Sun SQ
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10415-32. PubMed ID: 26454868
[TBL] [Abstract][Full Text] [Related]
36. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains.
LoBue AD; Lindesmith L; Yount B; Harrington PR; Thompson JM; Johnston RE; Moe CL; Baric RS
Vaccine; 2006 Jun; 24(24):5220-34. PubMed ID: 16650512
[TBL] [Abstract][Full Text] [Related]
37. Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus.
Koho T; Huhti L; Blazevic V; Nurminen K; Butcher SJ; Laurinmäki P; Kalkkinen N; Rönnholm G; Vesikari T; Hytönen VP; Kulomaa MS
J Virol Methods; 2012 Jan; 179(1):1-7. PubMed ID: 21600929
[TBL] [Abstract][Full Text] [Related]
38. Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes.
Wei M; Zhang X; Yu H; Tang ZM; Wang K; Li Z; Zheng Z; Li S; Zhang J; Xia N; Zhao Q
Vaccine; 2014 May; 32(24):2859-65. PubMed ID: 24662711
[TBL] [Abstract][Full Text] [Related]
39. Development of Rous sarcoma Virus-like Particles Displaying hCC49 scFv for Specific Targeted Drug Delivery to Human Colon Carcinoma Cells.
Kato T; Yui M; Deo VK; Park EY
Pharm Res; 2015 Nov; 32(11):3699-707. PubMed ID: 26047779
[TBL] [Abstract][Full Text] [Related]
40. Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization.
Brune KD; Leneghan DB; Brian IJ; Ishizuka AS; Bachmann MF; Draper SJ; Biswas S; Howarth M
Sci Rep; 2016 Jan; 6():19234. PubMed ID: 26781591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
